Your search for

2 results were returned

  1. Twobirds news
    30 May 2019
    International team advises Chiesi Farmaceutici on in-licence of Raxone® from Santhera
    www.twobirds.com/en/news/press-releases/2019/uk/international-team-advises-chiesi-farmaceutici-on-inlicence-of-raxone-from-santhera

    International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")

  2. Twobirds news
    15 March 2021
    Bird & Bird advises Kreos Capital on debt facilities for Branded E-Commerce Group
    www.twobirds.com/en/news/press-releases/2021/global/bird-and-bird-advises-kreos-capital-on-debt-facilities-for-branded-e-commerce-group

    The Bird & Bird Finance & Financial Regulation and Corporate teams advised Kreos Capital on debt facilities for the Branded E-Commerce Group (Branded).